© 2024 Four 20 Pharma
Paderborn 05.11.2021, After Four 20 Pharma GmbH has already successfully established itself in Germany as one of the leading quality providers of medical cannabis, the entry into the Czech market has now also been successfully implemented as part of the internationalization strategy for the year 2021/22. The products of the 420 NATURAL line have been registered and licensed in the Czech Republic and will be distributed exclusively by our partner with immediate effect.
Motagon is a pioneer in the field of medicinal cannabis in the Czech Republic and is further expanding its position with these new products. The first delivery of the well-known house brand "420 NATURAL" has already crossed the border and will now also supply patients throughout the Czech Republic.
"For us, this step is the start of our internationalization strategy. We are convinced that other European markets will follow our approach of focusing on non-irradiated products. We deliberately chose the Czech Republic because it is still a relatively small but very promising market and, of course, not least because of its direct proximity ", explains Thomas Schatton, CEO of Four 20 Pharma GmbH.
In the near future, other EU countries will follow and will be supplied with products from Four 20 Pharma GmbH.
For further information please visit www.420pharma.de.
About Four 20 Pharma GmbH
Four 20 Pharma GmbH is GDP and GMP certified as a manufacturer, wholesaler and importer of medical cannabis as well as medical devices. The company, based in Paderborn, Germany, was founded in 2018 and holds a narcotics license according to § 3 BtMG and a wholesale drug license according to § 52a AMG for the whole of Europe. In addition, the medical cannabis specialist holds the necessary import licenses for the importation of medical cannabis into Germany, a manufacturing permit, and the necessary, product-specific permit in accordance with § 7 AMG and § 1 AMRadV for the marketing of medicinal products. Four 20 Pharma GmbH is committed to the Association for Cannabis as Medicine (ACM) as a gold sponsor. The company supports physicians, pharmacies, medical institutions and patients as a reliable partner in the field of medical cannabis. For more information, please visit our website at www.420pharma.de.
